Nuveen Asset Management, LLC - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$1,782,000
+29.3%
445,390
+58.4%
0.00%0.0%
Q3 2019$1,378,000
-13.9%
281,259
+7.1%
0.00%0.0%
Q2 2019$1,600,000
-22.2%
262,589
+257.6%
0.00%
-91.7%
Q3 2016$2,057,000
+68.7%
73,432
+110.9%
0.01%
+71.4%
Q2 2016$1,219,00034,8150.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 369,015$12,916,0004.04%
OBERWEIS ASSET MANAGEMENT INC/ 237,515$8,313,0002.47%
WEATHERBIE CAPITAL, LLC 259,175$9,071,0001.29%
Summit Creek Advisors LLC 216,385$7,573,0001.29%
Cambridge Investment Research Advisors, Inc. 1,700,106$59,504,0001.26%
Hood River Capital Management LLC 265,388$9,289,0001.24%
Sivik Global Healthcare LLC 65,000$2,275,0001.13%
Friedberg Investment Management 63,430$2,220,0001.05%
Granite Investment Partners, LLC 342,839$12,000,0000.95%
Tributary Capital Management, LLC 176,289$6,170,0000.90%
View complete list of DIPLOMAT PHARMACY INC shareholders